Harry V Vinters Selected Research

Amyloid beta-Peptides

12/2021	Exosomal tau with seeding activity is released from Alzheimer's disease synapses, and seeding potential is associated with amyloid beta.
7/2021	Cerebral Amyloid Angiopathy-related Inflammation Presenting With a Cystic Lesion in Young-onset Alzheimer Disease.
11/2012	Extensive p-tau pathology and SDS-stable p-tau oligomers in Alzheimer's cortical synapses.
3/2012	Isolation of synaptic terminals from Alzheimer's disease cortex.
1/2012	Apolipoprotein E level and cholesterol are associated with reduced synaptic amyloid beta in Alzheimer's disease and apoE TR mouse cortex.
1/2012	Preferential accumulation of amyloid-beta in presynaptic glutamatergic terminals (VGluT1 and VGluT2) in Alzheimer's disease cortex.
4/2011	High levels of synaptosomal Na(+)-Ca(2+) exchangers (NCX1, NCX2, NCX3) co-localized with amyloid-beta in human cerebral cortex affected by Alzheimer's disease.
8/2010	Synapse loss in dementias.
7/2009	Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin.
4/2009	Reduction of SorLA/LR11, a sorting protein limiting beta-amyloid production, in Alzheimer disease cerebrospinal fluid.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Harry V Vinters Research Topics

Disease

50	Alzheimer Disease (Alzheimer's Disease) 12/2023 - 03/2002
20	Epilepsy (Aura) 02/2021 - 02/2004
18	Malformations of Cortical Development 02/2021 - 02/2004
16	Tuberous Sclerosis (Bourneville's Disease) 02/2021 - 08/2002
14	Dementia (Dementias) 03/2024 - 01/2006
14	Neoplasms (Cancer) 05/2022 - 09/2002
12	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2023 - 01/2002
11	Amyloid Plaque 01/2022 - 01/2006
11	Stroke (Strokes) 01/2019 - 01/2002
10	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 10/2018 - 05/2002
9	Parkinson Disease (Parkinson's Disease) 01/2023 - 01/2005
9	Inflammation (Inflammations) 07/2021 - 06/2007
8	Focal Cortical Dysplasia 01/2021 - 10/2004
8	Infarction (Infarctions) 12/2018 - 05/2002
7	Seizures (Absence Seizure) 01/2021 - 02/2004
6	Cognitive Dysfunction 12/2022 - 09/2006
6	Hemimegalencephaly 01/2021 - 04/2002
5	Encephalitis (Encephalitis, Rasmussen) 01/2021 - 10/2004
5	Ischemia 07/2013 - 01/2002
4	Gliosis 02/2021 - 10/2009
4	Tauopathies 01/2020 - 07/2003
4	Glioma (Gliomas) 01/2019 - 09/2002
4	Glioblastoma (Glioblastoma Multiforme) 05/2013 - 09/2002
4	Thrombosis (Thrombus) 05/2013 - 07/2007
4	Temporal Lobe Epilepsy 03/2012 - 10/2004
3	Drug Resistant Epilepsy 12/2023 - 09/2006
3	HIV Infections (HIV Infection) 01/2022 - 08/2012
3	Ischemic Stroke 01/2019 - 05/2010
3	Neuroinflammatory Diseases 01/2019 - 06/2007
3	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2015 - 02/2010
3	Neurologic Manifestations (Neurological Manifestations) 12/2014 - 05/2002
3	Amyloid angiopathy 06/2014 - 05/2002
3	Brain Neoplasms (Brain Tumor) 07/2013 - 11/2011
3	Neurocognitive Disorders (Clerambault Syndrome) 11/2012 - 08/2012
3	Hippocampal Sclerosis 01/2012 - 12/2006
3	Hemorrhage 12/2010 - 03/2010
3	Aneurysm (Aneurysms) 07/2010 - 07/2007
3	Hypoxia (Hypoxemia) 06/2006 - 05/2002
2	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 03/2024 - 08/2010
2	B-Cell Lymphoma (Lymphoma, B Cell) 08/2023 - 01/2019
2	Synucleinopathies 01/2023 - 01/2023
2	Intellectual Disability (Idiocy) 02/2021 - 11/2011
2	Angiofibroma 02/2021 - 03/2003
2	Lymphoma (Lymphomas) 01/2019 - 01/2011
2	Neoplasm Metastasis (Metastasis) 01/2019 - 01/2019
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2019 - 07/2002
2	Lacunar Stroke 03/2015 - 03/2010
2	Ataxia Telangiectasia (Louis Bar Syndrome) 12/2014 - 05/2011
2	Hyperplasia 01/2013 - 09/2007

Drug/Important Bio-Agent (IBA)

28	Amyloid (Amyloid Fibrils)IBA 12/2023 - 03/2002
20	Proteins (Proteins, Gene)FDA Link 12/2023 - 05/2002
15	trans-sodium crocetinate (crocetin)IBA 02/2021 - 08/2002
14	Amyloid beta-PeptidesIBA 12/2021 - 03/2002
6	AntibodiesIBA 10/2023 - 03/2003
6	IronIBA 01/2023 - 05/2007
6	Biomarkers (Surrogate Marker)IBA 12/2022 - 09/2006
6	ApolipoproteinsIBA 01/2019 - 03/2002
5	Apolipoprotein E4IBA 01/2019 - 03/2002
5	Apolipoproteins E (ApoE)IBA 01/2019 - 01/2012
4	SynucleinsIBA 01/2023 - 01/2013
4	RNA (Ribonucleic Acid)IBA 01/2023 - 05/2013
4	gamma-Aminobutyric Acid (GABA)IBA 01/2020 - 01/2007
4	LigandsIBA 01/2019 - 09/2002
4	PolymersIBA 09/2017 - 07/2007
4	Peptides (Polypeptides)IBA 12/2016 - 05/2002
3	LipidsIBA 09/2019 - 01/2019
3	Sirolimus (Rapamycin)FDA Link 12/2018 - 12/2009
3	Glial Fibrillary Acidic ProteinIBA 01/2018 - 02/2004
3	ParaffinIBA 01/2017 - 10/2004
3	Formaldehyde (Formol)FDA Link 01/2017 - 10/2009
3	ErbB Receptors (EGF Receptor)IBA 05/2013 - 09/2002
3	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 12/2011 - 05/2002
3	CopperIBA 01/2011 - 05/2007
3	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 10/2008 - 06/2004
2	PrionsIBA 10/2023 - 11/2019
2	HemosiderinIBA 01/2023 - 03/2010
2	alpha-SynucleinIBA 01/2023 - 08/2002
2	ChemokinesIBA 12/2022 - 05/2013
2	tau Proteins (tau Protein)IBA 01/2022 - 07/2003
2	Tissue ExtractsIBA 01/2020 - 11/2019
2	Monoclonal AntibodiesIBA 01/2019 - 01/2019
2	pleiotrophin (HARP)IBA 01/2017 - 02/2015
2	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 01/2017 - 11/2010
2	TOR Serine-Threonine KinasesIBA 04/2015 - 12/2009
2	Retinaldehyde (Retinal)IBA 03/2015 - 07/2013
2	Phosphotransferases (Kinase)IBA 12/2014 - 05/2011
2	Ataxia Telangiectasia Mutated ProteinsIBA 12/2014 - 05/2011
2	Prostaglandins AIBA 02/2014 - 07/2007
2	ElementsIBA 07/2013 - 01/2013
2	Messenger RNA (mRNA)IBA 05/2013 - 06/2006
2	3-(2,2,2-trimethylhydrazine)propionateIBA 05/2013 - 11/2010
2	Neuroprotective AgentsIBA 05/2013 - 05/2002

Therapy/Procedure

16	Therapeutics 03/2024 - 09/2002
5	Hemispherectomy 02/2006 - 04/2002
3	Radiotherapy 11/2015 - 09/2003
2	Highly Active Antiretroviral Therapy (HAART) 01/2022 - 08/2002
2	Craniotomy 12/2020 - 09/2007
2	Intravenous Injections 01/2019 - 05/2002
2	Aftercare (After-Treatment) 07/2013 - 01/2013
2	Stents 07/2013 - 01/2013